Medical eligibility, contraceptive choice, and intrauterine device acceptance among HIV-infected women receiving antiretroviral therapy in Lilongwe, Malawi.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 4149777)

Published in Int J Gynaecol Obstet on May 13, 2014

Authors

Lisa B Haddad1, Caryl Feldacker2, Denise J Jamieson3, Hannock Tweya4, Carrie Cwiak3, Amy G Bryant5, Mina C Hosseinipour6, Thomas Chaweza4, Linly Mlundira4, Fanny Kachale7, Gretchen S Stuart5, Irving Hoffman5, Sam Phiri4

Author Affiliations

1: Emory University, Department of Gynecology and Obstetrics, Atlanta, USA. Electronic address: lbhadda@emory.edu.
2: The Lighthouse Trust, Lilongwe, Malawi; International Training and Education Center for Health (I-TECH), University of Washington, Seattle, USA.
3: Emory University, Department of Gynecology and Obstetrics, Atlanta, USA.
4: The Lighthouse Trust, Lilongwe, Malawi.
5: University of North Carolina-Chapel Hill, Chapel Hill, USA.
6: University of North Carolina-Chapel Hill, Chapel Hill, USA; University of North Carolina Project-Malawi, Lilongwe, Malawi.
7: Reproductive Health Services, Ministry of Health, Lilongwe, Malawi.

Articles cited by this

Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96

Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it. Contraception (2008) 3.09

Complications of use of intrauterine devices among HIV-1-infected women. Lancet (1998) 2.50

The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis (2007) 1.75

Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS (2012) 1.41

Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis. BJOG (2012) 1.24

Hormonal contraception and HIV-1 transmission. Am J Reprod Immunol (2010) 1.13

Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz. Contraception (2011) 1.12

HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS (2009) 1.12

Is the intrauterine device appropriate contraception for HIV-1-infected women? BJOG (2001) 1.12

Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle. J Infect Dis (1998) 1.11

Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy. Infect Dis Obstet Gynecol (2012) 1.09

Determinants of contraceptive choice among women with HIV. AIDS (2009) 1.04

Effect of intrauterine device use on cervical shedding of HIV-1 DNA. AIDS (1999) 1.03

Impact of long-term contraceptive promotion on incident pregnancy: a randomized controlled trial among HIV-positive couples in Lusaka, Zambia. J Acquir Immune Defic Syndr (2013) 0.95

Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate. Contraception (2013) 0.82